CliniciansAbout
Media
BlogNews
Buy now
Broadening the Scope of Clinical Trials: The Changing Role of Real-World Evidence
March 15, 2023
The role that real-world evidence, and the data that feeds into it, play in the clinical trials arena is changing. For many years, drug developers and regulators have collected real-world data (RWD) on adverse events linked to newly approved medicines. However, this data has not played a significant role in developing or executing pre-approval clinical trials. The situation is now changing. “There’s always been a need to look at how drugs that are coming out of clinical trials behave in the real world,” Gracy Crane, International Regulatory Policy Lead for RWD at Roche in the U.K., told Inside Precision Medicine.
Read Now
Ontario Brain Institute, Epilepsy Ottawa, Neureka® Partner to Make Technology More Accessible to People with Epilepsy
February 15, 2023
In a collaborative effort to improve the quality of life of people with neurological conditions, the Ontario Brain Institute, Epilepsy Ottawa, and Neureka® (Neureka AI) completed a groundbreaking community study to make epilepsy-management technology more accessible to Canadians. The study results showed significant increases in patients’ quality of life and health, with improved engagement with their care partners.
Read Now
Service-disabled Veteran-owned Academy Medical Inc. Announces Distribution Agreement for Neureka® Products, Joins SUDEP Data Alliance
January 25, 2023
Academy Medical Inc. announced this week that the company has signed a distribution agreement with Novela Neurotechnologies Inc. DBA Neureka AI for Neureka® products.
Read Now
SUDEP Data Alliance Founded to Develop Life-Saving Interventions for SUDEP
December 2, 2022
The SUDEP Data Alliance announces its creation of the world’s first open data network with a mission to accelerate the development of new life-saving interventions to prevent Sudden Unexpected Death in Epilepsy (SUDEP). Cofounded by Neureka® (Neureka AI) and Briya, the SUDEP Data Alliance provides unprecedented real-world data that unites a global community of researchers, nonprofits, mission-driven companies, and people impacted by epilepsy.
Read Now
Neureka®️ Sleep Provides At-Home Monitoring for Epilepsy Patients with SUDEP Risk
July 20, 2022
Novela Neurotechnologies, a leading provider of continuous neurology care, has launched Neureka® Sleep, an AI-powered wearable sleep monitor, to bring peace of mind to epilepsy patients and their families who worry about nocturnal seizures, which may lead to Sudden Unexpected Death in Epilepsy (SUDEP).
Read Now
Novela Neurotechnologies Acquires 510(k)-Cleared Seizure-Detection Assets from Brain Sentinel
June 1, 2022
Novela Neurotechnologies Inc., a digital health company specializing in continuous, data-driven epilepsy care, acquires the complete intellectual property (IP) portfolio of Brain Sentinel Inc., former manufacturer of the SeizureLink™ wearable and 510(k)-cleared seizure-monitoring SPEAC® System. The acquisition spans 58 patents and applications and positions Novela at the forefront of epilepsy care.
Read Now
Novela Neurotech Joins the 2021 UCSF Rosenman Innovators
June 17, 2021
Novela Neurotech, a leader in remote neurological care based in Alameda, California, is selected as part of the 2021 cohort of the Rosenman Innovators. Based at the University of California, San Francisco (UCSF), Rosenman Innovators are a prestigious group of early-stage companies chosen for their innovative technologies and patient impact.
Read Now
Novela Neurotech Joins Sofie’s Journey in a Strategic Partnership to Promote Epilepsy Awareness
March 30, 2021
Novela Neurotech, a digital healthcare company specializing in personalized remote care for epilepsy and other neurological conditions, announces a strategic partnership with Sofie’s Journey to promote epilepsy awareness and access to cutting-edge epilepsy care solutions.
Read Now
Novela Neurotech Partners with Epilepsy Advocate Brain Ablaze in Memorable Motto Challenge to Raise Epilepsy Awareness
December 8, 2020
This year we partnered with Novela Neurotech to bring a bit of fun to our Epilepsy Awareness Month with our Memorable Motto Challenge. Novela Neurotech then used the motto “The Patients are the Experts!” in a wonderfully designed T-shirt hosted in our store.
Read Now
Novela Neurotech's neureka® 2020 Epilepsy Challenge featured at IEEE Signal Processing in Medicine and Biology Symposium
December 5, 2020
To celebrate the 10th year of the symposium, we are collaborating with Novela Neurotech and NeuroTechX to host the neureka 2020 Epilepsy Challenge.
Read Now
Novela Neurotech to Present neureka® for Epilepsy Platform at Epilepsy Awareness Day at Disneyland
October 30, 2020
Novela Neurotech, a NeuroData company enabling personalized remote care for chronic neurological conditions, will showcase its nEureka® for Epilepsy smartwatch-based platform at the virtual Epilepsy Awareness Day at Disneyland (EADDL), November 2 at 9:30 AM PT.
Read Now
Novela Neurotech to Present neureka® for Epilepsy Platform at CapCon 2020 Venture Conference
September 23, 2020
Novela Neurotech, a Data-as-a-Service company developing personalized remote epilepsy care using connected consumer data, will showcase its neureka® for Epilepsy platform at the virtual CapCon 2020 Venture Conference, Sep 29 to Oct 1, 2020.
Read Now
Novela Neurotech Featured on Epilepsy Foundation NorCal's Research Spotlight
August 5, 2020
Research and development of new tools to fight and better understand seizures are critical aspects of our mutual goal to create a seizure-free world. We want to help organizations get your feedback and participation to shorten the time for those tools to get to market.
Read Now
How a Crowdsourcing Challenge Turbocharged Brain Research During Lockdown
June 2, 2020
In mid-March, a trifecta of academic, non-profit, and commercial neurotech companies united to launch a neuroscientific challenge that embodied a more collaborative future for solving the brain, while physically apart and working from home.
Read Now
Novela Neurotech Seeks to Accelerate Neurological Treatments with Brain Decoding as a Service
June 1, 2020
Novela Neurotech is a spin off from a Canadian university, the University of Waterloo. We have a long track record of university research and development in what we call the field of neuromodulation, which is basically a way to alter brain functions through different modalities, such as using electricity to change the way brain cells communicate.
Read Now
“Biomed Irregulars” Won The First Place In nEureka Challenge!!!
May 29, 2020
A researcher team from STADIUS: “Biomed Irregulars” won the first place in Neureka Challenge!!! Neureka challenge was a month-long challenge organized by Novela Neurotech and NeuroTechX on seizure prediction using the TUH EEG Seizure dataset (one of the biggest available seizure datasets).
Read Now
Novela Neurotech Appoints Aiman Abdel-Malek, Ph.D., to Board of Directors
April 27, 2020
As a highly experienced business strategic visionary leader, Dr. Abdel-Malek will support Novela in discovering dynaceutical therapies for brain disorders.
Read Now
Novela Neurotech joins INCF's Industry Advisory Council to advance open neuroscience
April 23, 2020
By partnering with INCF, one of the world’s largest institutions promoting data and software reuse and reproducibility in brain research, Novela positions itself as an industry leader in neuroscience data sharing and collaboration.
Read Now
Novela Featured in San Francisco Business Times: An Island of Innovation
April 15, 2020
Alameda is known for many things—among them, the monthly antiques fair, the former Naval Air Station and the U.S.S. Hornet, spirits distilleries, a vintage pinball museum, and as the birthplace of popsicles and creamy peanut butter.
Read Now
Online Neureka™ challenge launches to crowdsource EEG solutions for epilepsy
April 1, 2020
Novela Neurotech and NeuroTechX are teaming up in an effort to accelerate epilepsy research
Read Now
5 Top Emerging Neurotechnology Startups
March 15, 2020
The US-based startup Novela Neurotechnology builds Neureka, a smart platform to understand and decode neurological activity in the brain using artificial intelligence. Neureka, the startup’s platform combines smart neural interfaces and scheduled delivery of neuromodulation that results in accelerated drug discovery.
Read Now
CRANIA to host collaborative neuromodulation workshop with Novela Neurotech and Hahn-Schickard
February 6, 2020
CRANIA, Novela Neurotech and Hahn-Schickard unites to accelerate the translation of Novela’s open source neuromodulation research kit.
Read Now
Novela Neurotech teams up with UCSF to break down neurodata borders
February 4, 2020
Novela Neurotech teams up with UCSF to break down neurodata borders. Just as computer scientists developed standards to deliver digital content across the globe to your laptop, neuroscientists are working to break down barriers in data sharing.
Read Now
Novela Neurotech begins testing wireless, read-write capable brain prosthesis
November 12, 2019
Consciousness is one of the brain’s most enigmatic mysteries. A new theory, inspired by thermodynamics, takes a high-level perspective of how neural networks in the brain transiently organize to give rise to memories, thought and consciousness.
Read Now
Novela’s Neureka™ and the Future of Neurostimulation
July 1, 2019
“Neurostimulation is emerging as a novel non-pharmacological way of treating brain disorders and is showing far greater efficacy with fewer side effects.”
Read Now
In The Press
January 24, 2019
Novela’s hometown newspaper the Alameda Sun featured us in their Thursday 1/24/19 issue “Novela’s long-term vision is to extend memory and brain processing speed, and even to add built-in cloud connectivity as well as expand human senses.”
Read Now
United States
1101 Marina Village Pkwy
Suite 201
Alameda, California, 94501
USA
Canada
1 Dundas St. W #2500
Toronto,
ON M5G 1Z3
Canada
Privacy policy
Return policy
Annual subscription renewal
Stay up to date with Neureka
Sign up for our newsletter & follow us on social media to stay connected with us!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
hello@neureka.ai